Drug profile · INN
infliximab-dyyb
ZYMFENTRA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
infliximab-dyyb (ZYMFENTRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN infliximab-dyyb
Brand ZYMFENTRA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is infliximab-dyyb?
infliximab-dyyb (ZYMFENTRA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for infliximab-dyyb?
ZYMFENTRA is a marketed brand name for infliximab-dyyb. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of infliximab-dyyb?
infliximab-dyyb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.